PPIB and Hyperhidrosis: Thirty-eight consenting patients with craniofacial hyperhidrosis were consecutively enrolled to primarily evaluate the clinical effect of BoNT-B in craniofacial hyperhidrosis 2–4 weeks post-treatment and secondarily to investigate the duration of the therapeutic effects and safety of the treatment.